SCHEMBL19080050

SCHEMBL19080050

c1ccc(-c2c3ccccc3c(-c3ccc4cc(-c5ccc6c(ccc7c6oc6c8ccccc8c8ccccc8c76)c5)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 8/20 0.40
CYP1B1 Q16678 8/20 0.40
ESR1 P03372 3/20 0.40
ESR2 Q92731 3/20 0.40
CYP1A2 P05177 9/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2D6 P10635 3/20 0.39
CYP2C9 P11712 3/20 0.39
CYP2B6 P20813 3/20 0.39
CYP2C19 P33261 3/20 0.39
ABCG2 Q9UNQ0 3/20 0.39
HSD17B1 P14061 2/20 0.39
HSD17B2 P37059 2/20 0.39
ABCB1 P08183 2/20 0.39
ABCC1 P33527 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PDE5A O76074 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079927 0.96 ESR1 (0.43) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL22260282 0.94 ESR1 (0.44) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL19080042 0.94 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2CYP3A4CYP2D6
SCHEMBL19079996 0.93 CYP1A1 (0.45) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL19080107 0.93 CYP1A1 (0.47) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL19080044 0.89 ESR1 (0.38) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL19080039 0.89 CYP1A1 (0.50) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL19079992 0.88 CYP1A1 (0.46) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL19080029 0.88 ARSA (0.38) CYP1A1CYP1B1ESR1ESR2CYP1A2
SCHEMBL19079941 0.88 CYP1A2 (0.38) CYP1A1CYP1B1ESR1ESR2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ESR1 153/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ESR1 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.